OrCam Technologies, innovator of life-changing, personal 'AI as a companion' solutions, has announced the UK launch of the OrCam Read 3, an all-in-one solution for people with vision loss or reading fatigue, or who find reading challenging.
Decades have passed and the influence of analysing fundus images by grading consultants and retinal image specialists has grown worldwide. Their job is to specialise in assessing hundreds of diagnosed eye disease disorders and to read thousands of eye images,...
20 years of Vision Care for Homeless People, and the 18,000+ people who have been helped to better vision through the regional drop-in clinics, were celebrated by a host of volunteers, charity founders and generous donors from the optical community last week.
Arriving in London on a wet Tuesday evening, I disembarked the train and began my expedition through the torrential rain, my drenched suit bag in one hand and my precious poster packaged and clutched to my chest in the other.
There are currently 600,000 people on the NHS waiting list for ophthalmology treatment, and over 5 million people in the UK currently live with dry eye disease. Here Andy Hill, CEO at NuVision Biotherapies Ltd, discusses a recent update to clinical guidelines and what this means for optometrists, patients, and taxpayers.
Scientists are working on a new device that could lead to a reduction in the number of people who go blind from age-related macular degeneration (AMD).
When I was a junior doctor in the late 1990s writing my first scientific papers, once each article was finished, I had to fill out an application form, print out multiple copies and then walk to the post office at...
The OSA is urging practices to adopt a forward-thinking approach and to make investment decisions for a five-year business plan, as the industry and profession meet at 100% Optical 24-26 February.
The Sir Jules Thorn Charitable Trust has awarded £5 million to UCL in partnership with Moorfields Eye Charity and Moorfields Eye Hospital to support Oriel – a centre for advancing eye health, opening in 2027.
Polypoidal choroidal vasculopathy (PCV) is a variant of neovascular AMD. It is a disease of choroidal vasculature characterised by abnormal branching vascular network with aneurysmal dilatations (polyps). Features of PCV include pigment epithelial detachments (PED), subretinal fluid (SRF) accumulation and...
The SCONe project, run by optometrists, ophthalmologists, and researchers from the University of Edinburgh, and funded by Sight Scotland, is appealing for participants to take part in a Patient and Public Involvement (PPI) group focused on revolutionising the detection and management of Age-Related Macular Degeneration (AMD).